Compare medicines
Put up to three medicines side by side. Useful for alternatives in the same class, or for seeing how two very different treatments differ.
| Attribute | ||
|---|---|---|
| In short | First-generation EGFR tablet for mutated lung cancer. | EGFR tablet for lung cancers with EGFR mutations. |
| Body system | Cancer | Cancer |
| Drug class | Tyrosine kinase inhibitors | Tyrosine kinase inhibitors |
| Supply | Prescription onlyWHO essential medicine | Prescription onlyWHO essential medicine |
| Main uses | EGFR-mutated non-small-cell lung cancer | EGFR-mutated non-small-cell lung cancer, Pancreatic cancer (with gemcitabine) |
| How it works | Blocks a growth signal in EGFR-mutated lung cancer. | Blocks a growth signal in EGFR-mutated lung cancer. |
| Starts working | Depends on the cancer and regimen | Depends on the cancer and regimen |
| Half-life | About 48 hours | About 36 hours |
| Typical adult dose | Dosed by your cancer team according to the treatment protocol. | Dosed by your cancer team according to the treatment protocol. |
| Forms | Tablet | Tablet |
| Common side effects | Acne-like rash, Diarrhoea, Dry skin, Nausea, Tiredness | Acne-like rash, Diarrhoea, Dry skin, Loss of appetite, Tiredness |
| Serious side effects | Lung inflammation, Liver injury, Bowel perforation | Lung inflammation, Liver failure, Bowel perforation, Eye problems |
| Don't take if | Pregnancy; Severe liver impairment | Pregnancy; Severe liver impairment |
| Alcohol | Best to limit. Alcohol may add to liver strain. | Best to limit. Alcohol may add to liver strain. |
| Pregnancy | Usually avoidedAvoid. | Usually avoidedAvoid. |
| Breastfeeding | Usually avoidedAvoid. | Usually avoidedAvoid. |
| In use since | — | — |
| Brand names | United States: IressaUnited Kingdom: IressaIndia: Iressa, Gefitinib (generic) | United States: TarcevaUnited Kingdom: TarcevaIndia: Tarceva, Erlonib, Erlotinib (generic) |
| Legal status | United States: Prescription onlyUnited Kingdom: Prescription-only medicine (POM)India: Schedule H | United States: Prescription onlyUnited Kingdom: Prescription-only medicine (POM)India: Schedule H |
| ATC code | L01EB01 | L01EB02 |
Taken together
No interaction between these medicines is recorded in the atlas.
Open in the interaction checker